Literature DB >> 15253330

Prevalence of Parkinson's disease in populations of African ancestry: a review.

Aideen McInerney-Leo1, Katrina Gwinn-Hardy, Robert L Nussbaum.   

Abstract

There have been a number of studies looking at the prevalence of Parkinson's disease (PD) in different racial and geographical populations. Some of the earliest studies suggested a difference in the prevalence of PD in African Americans as compared with Caucasians. As such a difference would have important implications for healthcare and research into the etiology of PD, we undertook a review of published studies to determine whether evidence suggested that such a difference exists. We reviewed 20 studies that looked at incidence, prevalence, and percentages of neurology patients with PD and Parkinsonism in Africa and in African-American populations. Two of these were door-to-door studies that relied on questionnaires for initial ascertainment, another was performed by review of outpatient records of a large health maintenance organization, while the remainder were based on hospital admissions, diagnosis in the community, or death certificate reports. In the aggregate, these studies suggest PD may be less frequent among Africans and African Americans than among Caucasians, although the most well-designed study showed only a statistically insignificant reduction in the prevalence of PD among African Americans. Although an apparently lower disease frequency among people of African origin may have a basis in the pathobiology of the disease, nearly all of these studies were vulnerable to a variety of ascertainment biases, and many lacked stringent application of diagnostic criteria applied by specialists trained in movement disorders. We conclude that a difference in the prevalence of PD and Parkinsonism between black and other populations is unproven and will require additional well-designed studies to determine if previously reported ethnic differences in disease prevalence are real.

Entities:  

Mesh:

Year:  2004        PMID: 15253330      PMCID: PMC2568420     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  22 in total

1.  Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies.

Authors:  V L Shavers; C F Lynch; L F Burmeister
Journal:  J Natl Med Assoc       Date:  2000-12       Impact factor: 1.798

2.  Ethnic differences and disease phenotypes.

Authors:  John Hardy; Andrew Singleton; Katrina Gwinn-Hardy
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

3.  Use of latent class analyses for the estimation of prevalence of cognitive impairment, and signs of stroke and Parkinson's disease among African-American elderly of central Harlem: results of the Harlem Aging Project.

Authors:  J A Teresi; S M Albert; D Holmes; R Mayeux
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

4.  Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.

Authors:  Anjali S Advani; Benjamin Atkeson; Carrie L Brown; Bercedis L Peterson; Laura Fish; Jeffrey L Johnson; Jon P Gockerman; Marc Gautier
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

5.  Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans.

Authors:  R M Paddison; R P Griffith
Journal:  Neurology       Date:  1974-07       Impact factor: 9.910

6.  Epidemiologic studies of Parkinson's disease. II. A hospital-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-04       Impact factor: 4.897

7.  Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Authors:  I I Kessler
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

8.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

Review 9.  Systematic review of incidence studies of Parkinson's disease.

Authors:  Dominique Twelves; Kate S M Perkins; Carl Counsell
Journal:  Mov Disord       Date:  2003-01       Impact factor: 10.338

10.  Modulations of signal transduction pathways during sepsis and the effects of insulin and mifepristone.

Authors:  Subir R Maitra; Elliott Chen; Dominik Rosa; Patrick D Valane; M Raafat El-Maghrabi; Collin E M Brathwaite
Journal:  Acad Emerg Med       Date:  2003-01       Impact factor: 3.451

View more
  17 in total

1.  Minority enrollment in Parkinson's disease clinical trials.

Authors:  Myra G Schneider; Christopher J Swearingen; Lisa M Shulman; Jian Ye; Mona Baumgarten; Barbara C Tilley
Journal:  Parkinsonism Relat Disord       Date:  2008-08-09       Impact factor: 4.891

2.  Interpreting methamphetamine levels in a high-use community.

Authors:  Aurea C Chiaia-Hernandez; Caleb J Banta-Green; Jennifer A Field
Journal:  Environ Sci Pollut Res Int       Date:  2011-04-21       Impact factor: 4.223

3.  Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation.

Authors:  Andrea Sylvia Winkler; Esra Tütüncü; Anna Trendafilova; Michael Meindl; John Kaaya; Erich Schmutzhard; Jan Kassubek
Journal:  J Neurol       Date:  2009-12-19       Impact factor: 4.849

4.  Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study.

Authors:  Talene A Yacoubian; George Howard; Brett Kissela; Charles D Sands; David G Standaert
Journal:  Neuroepidemiology       Date:  2009-11-04       Impact factor: 3.282

Review 5.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

6.  Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability.

Authors:  Nabila Dahodwala; Jason Karlawish; Andrew Siderowf; John E Duda; David S Mandell
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

7.  Treatment disparities in Parkinson's disease.

Authors:  Nabila Dahodwala; Ming Xie; Elizabeth Noll; Andrew Siderowf; David S Mandell
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

8.  Factors influencing physician referrals of patients to clinical trials.

Authors:  Arch G Mainous; Daniel W Smith; Mark E Geesey; Barbara C Tilley
Journal:  J Natl Med Assoc       Date:  2008-11       Impact factor: 1.798

9.  Genetic determinants of hair color and Parkinson's disease risk.

Authors:  Xiang Gao; Kelly C Simon; Jiali Han; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

10.  Prevalence and Correlates of Anti-Parkinson Drug Use in a Nationally Representative Sample.

Authors:  Nabila Dahodwala; Allison W Willis; Pengxiang Li; Jalpa A Doshi
Journal:  Mov Disord Clin Pract       Date:  2016-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.